Bottom line
PBE vs INVN: the short answer
PBE (Invesco Biotechnology & Genome ETF) and INVN (Alger Russell Innovation ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
INVN is cheaper at 0.55% vs 0.59% — a difference of $4.00 a year per $10,000 invested.
Updated Nov 19, 2026
PBE vs INVN side by side
| PBE | INVN | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Invesco | Alger |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.59% | 0.55% |
| Annual cost per $10k | $59 | $55 |
| 10-yr cost on $10k (prospectus) | $738 | $1,495 |
| Max front load | None | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +24.7% | — |
| 5-yr return (annualized) | +3.4% | — |
| 10-yr return (annualized) | +5.2% | — |
| Best quarter | +25.3% | — |
| Worst quarter | −24.3% | — |
| Net assets (fund) | $281.9M | $9.6M |
| Number of holdings | 33 | 51 |
| Portfolio turnover | 103% | 68% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
5 of PBE's top 25 holdings also appear in INVN's top 25.
| Holding | PBE | INVN |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 5.47% | 2.03% |
| Biogen Inc. | 4.79% | 2.18% |
| Incyte Corp. | 3.06% | 2.11% |
| Neurocrine Biosciences, Inc. | 2.66% | 2.06% |
| Exelixis, Inc. | 2.64% | 2.03% |
Source: SEC Form N-PORT
PBE top 10
- Invesco Private Prime Fund — 12.89%
- Regeneron Pharmaceuticals, Inc. — 5.47%
- Amgen Inc. — 5.22%
- CareDx, Inc. — 5.04%
- Vertex Pharmaceuticals Inc. — 4.99%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Biogen Inc. — 4.79%
- Gilead Sciences, Inc. — 4.43%
- United Therapeutics Corp. — 4.08%
INVN top 10
- Roblox Corp — 2.57%
- Zebra Technologies Corp — 2.38%
- Expedia Group Inc — 2.29%
- Maplebear Inc — 2.25%
- Block Inc — 2.24%
- Zscaler Inc — 2.22%
- Bill Holdings Inc — 2.19%
- Biogen Inc — 2.18%
- Ccc Intelligent Solutions Holdings Inc — 2.15%
- Etsy Inc — 2.15%
FAQ
What is the difference between PBE and INVN?
PBE (Invesco Biotechnology & Genome ETF) and INVN (Alger Russell Innovation ETF) are quite different portfolios: only about 16% of their top holdings (by weight) are shared. INVN is cheaper at 0.55% vs 0.59% — a difference of $4.00 a year per $10,000 invested.
Which is cheaper, PBE or INVN?
INVN has the lower expense ratio (0.55%).
Should I own both PBE and INVN?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.